Form 4 for FULC Fulcrum Therapeutics, Inc.
Accepted 2025-05-09 00:00:00 ET · period of report 2025-05-08 · accession 0000950170-25-068038 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-09 | 2025-05-08 | FULC | Tourangeau Greg | Principal Accounting Off | S - Sale | $5.06 | -498 | 14.1K | -3% | -$2,520 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-08 | S | D | 498 | $5.06 | 14,062 | D | — | — | (F2) Includes 2,989 shares acquired under the Issuer's employee stock purchase plan on May 14, 2024. |